Science

…opposition to natural psychedelics & [entheogens/ethnobotanicals]?

A note about psychedelics and hallucinogens – These terms are often used interchangeably, which can be misleading. Many psychedelics [entheogens and ethnobotanicals] do not cause hallucinations at low doses. Therefore, using the blanket term hallucinogen to describe the effects of all doses of psilocybin [and psilocybin-containing mushrooms/psilocybe mushrooms], for example, is incorrect… Original Article (Psychedelic…

READ MORE
Science

[Does synthetic psilocybin]… cause nausea?

Some participants in studies using pure, synthetic psilocybin report nausea as a side effect of their treatment. This points the finger at [synthetic] psilocybin as a possible cause of nausea… Also, because the body quickly converts psilocybin to its active form psilocin, this suggests that psilocin may play a role in nausea. Original Article (Psychedelic…

READ MORE
Biography/Memoir

[Anesthetic dissociative] ketamine clinics [in] Los Angeles deemed ‘essential’ business…

…mental health clinic that provides IV ketamine infusions to treat mood disorders and chronic pain, is keeping its… facility open… Chief Operating Officer Sam Mandel says, “Our aim is to help patients and their families make well-informed decisions about their mental health by providing the latest data in a compassionate manner.”  Original Article (Digital Journal):Ketamine…

READ MORE
Biography/Memoir

…stable psilocybin supply under DEA Schedule I license

Via its vertically integrated… medicine… pursuing the development and commercialization… Dr. Michael Hoffer [otolaryngologists; also known ear, nose & throat doctors), has secured a sustainable supply of psilocybin under a DEA schedule I license, which will be used for ongoing psilocybin-based therapeutics studies. The psilocybin is to be provided by the same organization that has…

READ MORE
Science

Why chronic microdosing might [be risky to the] heart

There have been several FDA-approved medications with 5HT2B receptor activation withdrawn from the US market due to the risk of VHD with heart valve thickening and murmurs: Fen-Phen (fenfluramine/phentermine) and Redux (dexfenfluramine) in 1997 and Permax (pergolide) in 2007. Roughly 25% of patients taking these medications daily developed new onset VHD according to incidence statistics…

READ MORE